Dr. Magliocco on Pathologists in the Treatment of Melanoma

Anthony M. Magliocco, MD
Published: Thursday, Oct 10, 2013

Anthony M. Magliocco, MD, chair of pathology, executive director of esoteric labs at Moffitt Cancer Center, discusses the role of the pathologist in the treatment of a patient with melanoma.

Behind the primary practitioner, who is working with the patient directly, there is a team of experts that can help guide treatment by providing information on molecular genetics, therapy, and radiation oncology.

Magliocco says that a molecular pathologist can help a primary practitioner understand a tumor, the best technology platform to use, how to interpret data, and more. It is also essential for a primary practitioner to become familiar with the laboratories they are working with so that they can better understand the technologies, how they are changing, and what impact they can have on patients.

Anthony M. Magliocco, MD, chair of pathology, executive director of esoteric labs at Moffitt Cancer Center, discusses the role of the pathologist in the treatment of a patient with melanoma.

Behind the primary practitioner, who is working with the patient directly, there is a team of experts that can help guide treatment by providing information on molecular genetics, therapy, and radiation oncology.

Magliocco says that a molecular pathologist can help a primary practitioner understand a tumor, the best technology platform to use, how to interpret data, and more. It is also essential for a primary practitioner to become familiar with the laboratories they are working with so that they can better understand the technologies, how they are changing, and what impact they can have on patients.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Pediatric Hepatic Veno-Occlusive Disease: Integrating Novel Therapeutic Strategies to Overcome Post-Transplant ObstaclesMay 31, 20181.0
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Publication Bottom Border
Border Publication
x